MYBPC3 rs121908535: What Your Genotype Means
The rs121908535 variant is a rare genetic alteration located within the MYBPC3 gene. It is recognized in clinical research for its association with hypertrophic cardiomyopathy, a condition characterized by the thickening of the heart muscle.
What each genotype means
Typical genetic profile
This genotype represents the most common sequence found in the general population for this specific location in the MYBPC3 gene. It is not associated with the increased risk of hypertrophic cardiomyopathy linked to pathogenic variants in this gene. You should continue to follow standard heart health guidelines as recommended by your healthcare provider.
This is the most common genotype, found in the vast majority of the global population.
Increased cardiomyopathy risk
This genotype indicates the presence of a variant in one copy of the MYBPC3 gene, which is a well-established genetic factor associated with hypertrophic cardiomyopathy. Because this condition follows an autosomal dominant pattern, carrying this variant may increase the risk of heart muscle thickening, though the age of onset and severity can vary significantly between individuals. Please discuss these findings with a cardiologist or genetic counselor to determine if clinical screening or heart monitoring is appropriate for you.
This specific variant is rare in the general population, though it is a frequent cause of familial hypertrophic cardiomyopathy.
High risk profile
This genotype indicates that both copies of the MYBPC3 gene carry this variant, which is strongly associated with hypertrophic cardiomyopathy. Individuals with this profile may face a higher likelihood of developing significant heart muscle thickening compared to those with one copy. It is essential to consult with a cardiovascular specialist to discuss your clinical status and appropriate long-term management.
This homozygous genotype is extremely rare in the general population.
Understanding the Variant and Its Location
The rs121908535 variant is a specific change in the DNA sequence of the MYBPC3 gene. In genetics, a variant like this represents a single point of difference in the genetic code compared to the most common sequence found in the human population. The MYBPC3 gene is located on chromosome 11 and provides the blueprint for cardiac myosin-binding protein C, a critical component of the heart's contractile machinery. Because this variant is categorized as rare, it is not typically found in the general population at high frequencies. When researchers identify such variants, they analyze their position within the gene to determine if the change might disrupt the production or function of the resulting protein. Understanding the location of rs121908535 helps scientists predict how it might influence the structural integrity of heart muscle cells.
The Role of the MYBPC3 Gene
The MYBPC3 gene is essential for the proper function of the heart. It encodes cardiac myosin-binding protein C (cMyBP-C), which acts as a structural and regulatory protein within the sarcomeres, the basic units of muscle contraction in the heart. This protein helps organize the thick filaments of the heart muscle and modulates the interaction between actin and myosin, which is necessary for the heart to beat effectively. Research indicates that mutations in this gene often lead to a state of haploinsufficiency, where the body does not produce enough functional protein to maintain normal heart muscle structure. When this protein is absent or dysfunctional, the heart may undergo compensatory changes, such as thickening of the ventricular walls, which is the hallmark of hypertrophic cardiomyopathy. Maintaining the correct levels of cMyBP-C is vital for the heart's ability to pump blood efficiently throughout the body.
Research Associations and Evidence
The association between MYBPC3 variants and hypertrophic cardiomyopathy (HCM) is well-documented in medical literature. HCM is a condition where the heart muscle becomes abnormally thick, which can affect the heart's ability to pump blood and may lead to various clinical outcomes, ranging from no symptoms to severe heart failure or sudden cardiac death. The evidence linking specific pathogenic variants in MYBPC3 to HCM is considered strong, as these mutations are frequently identified in clinical testing of individuals diagnosed with the condition. Research suggests that these variants often result in a reduced 'super-relaxed' state of myosin, altering the mechanics of heart contraction. While the link between MYBPC3 and HCM is robust, the clinical expression of the disease can vary significantly between individuals, even those with the same genetic variant. This variability suggests that other genetic and environmental factors likely play a role in how the condition manifests.
What This Information Means for You
Genetic information regarding variants like rs121908535 is intended for educational purposes and should not be used for self-diagnosis or medical decision-making. If you have received results indicating the presence of this variant, it is important to consult with a qualified healthcare professional, such as a cardiologist or a genetic counselor. They can provide context based on your personal and family medical history, which is essential for interpreting the clinical significance of any genetic finding. You cannot determine your health status based on a single variant alone, as clinical outcomes are influenced by a complex interplay of genetics and lifestyle. Always discuss any concerns about heart health or genetic testing results with your clinician, who can guide you through appropriate screening, monitoring, or management strategies tailored to your specific needs.
How common is this variant?
The rs121908535 variant is rare in the general population. It is primarily identified in clinical settings among individuals undergoing testing for inherited heart conditions.
Frequently asked questions
What is the MYBPC3 gene?
The MYBPC3 gene provides instructions for making a protein called cardiac myosin-binding protein C. This protein is a key structural component of heart muscle cells that helps regulate contraction.
Is rs121908535 a cause of heart disease?
This variant is associated with an increased risk of hypertrophic cardiomyopathy. However, genetic associations are complex, and the presence of a variant does not guarantee that an individual will develop the condition.
Should I be worried if I have this variant?
If you have concerns about your genetic results, you should speak with a healthcare provider or a genetic counselor. They can help you understand what this means in the context of your personal health and family history.
How is hypertrophic cardiomyopathy diagnosed?
Hypertrophic cardiomyopathy is typically diagnosed by a cardiologist using tools like echocardiograms, cardiac MRIs, and physical examinations. Genetic testing is often used as a secondary tool to identify underlying causes.
Sources & further reading
Educational information only, last refreshed 9/30/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908535?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in MYBPC3
A common founder mutation (c.2827-2851del25) in the MYBPC3 gene strongly associated with hypertrophic cardiomyopathy in South Asian populations.
Pathogenic variant associated with hypertrophic cardiomyopathy.
Well-characterized founder variant (p.Pro955His) conferring autosomal dominant predisposition to adult-onset hypertrophic cardiomyopathy.
Variant associated with endurance-focused athletic performance and exercise-induced cardiac remodeling.